Pharmacological in vitro profiles of the enantiomers of BM5, a muscarinic partial agonist

被引：0
|
作者：
Sundquist, S
Nilvebrant, L
机构：
[1] Pharmacia & Upjohn Inc, Dept Pharmacol, SE-75182 Uppsala, Sweden
[2] Pharmacia & Upjohn Inc, Med Dept Urol, SE-75182 Uppsala, Sweden
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P530
引用
收藏
页码：R91 / R91
页数：1
相关论文
共 50 条
  • [21] F15063, an innovative antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (I) in vitro, neurochemical and neuroendocrine profiles
    Newman-Tancredi, A.
    Assie, M. B.
    Martel, J. C.
    Cosi, C.
    Heusler, P.
    Slot, L. Bruins
    Carilla-Durand, E.
    Cussac, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S144 - S145
  • [22] Synthesis, and in vitro and in vivo muscarinic pharmacological properties of a series of 1,6-dihydro-5-(4H)-pyrimidinone oximes
    Plate, R
    Plaum, MJM
    Pintar, P
    Jans, CG
    de Boer, T
    Dijcks, FA
    Ruigt, G
    Andrews, JS
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (09) : 1403 - 1420
  • [23] Pharmacological profiles of 5-HT2A Receptor (5-HT2AR):5-HT2CR Interactions In Vitro
    Zamora, J.
    Stafford, S.
    Mifflin, R.
    Gilbertson, S.
    Cunningham, K.
    Anastasio, N.
    FASEB JOURNAL, 2021, 35
  • [24] In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography
    Mogg, Adrian J.
    Eessalu, Thomas
    Johnson, Megan
    Wright, Rebecca
    Sanger, Helen E.
    Xiao, Hongling
    Crabtree, Michael G.
    Smith, Alex
    Colvin, Ellen M.
    Schober, Douglas
    Gehlert, Donald
    Jesudason, Cynthia
    Goldsmith, Paul J.
    Johnson, Michael P.
    Felder, Christian C.
    Barth, Vanessa N.
    Broad, Lisa M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (03): : 602 - 613
  • [25] The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
    Smith, J. A. M.
    Beattie, D. T.
    Marquess, D.
    Shaw, J. -P.
    Vickery, R. G.
    Humphrey, P. P. A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 378 (01) : 125 - 137
  • [26] The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
    J. A. M. Smith
    D. T. Beattie
    D. Marquess
    J.-P. Shaw
    R. G. Vickery
    P. P. A. Humphrey
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 378 : 125 - 137
  • [27] Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays
    Magdalena Jastrzębska-Więsek
    Agata Siwek
    Grzegorz Kazek
    Barbara Nawieśniak
    Anna Partyka
    Monika Marcinkowska
    Marcin Kołaczkowski
    Anna Wesołowska
    Pharmacological Reports, 2013, 65 : 998 - 1005
  • [28] Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays
    Jastrzebska-Wiesek, Magdalena
    Siwek, Agata
    Kazek, Grzegorz
    Nawiesniak, Barbara
    Partyka, Anna
    Marcinkowska, Monika
    Kolaczkowski, Marcin
    Wesolowska, Anna
    PHARMACOLOGICAL REPORTS, 2013, 65 (04) : 998 - 1005
  • [29] Similarities in antagonist affinity profiles of muscarinic M3 and M5 cholinoceptors:: Pharmacological difficulties associated with identifying a functional M5 receptor.
    Watson, N
    Choppin, A
    Hegde, SS
    Eglen, RM
    LIFE SCIENCES, 1999, 64 (6-7) : 557 - 557
  • [30] Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT4 receptor
    Komada, Tohru
    Matsuura, Tomomi
    Mikami, Tadayoshi
    Suzuki, Keiko
    Sugimoto, Hiromi
    Kimura, Naoji
    Ohmi, Takashi
    Toga, Tetsuo
    Nakai, Yasuhiro
    Eda, Hiroyuki
    Sakakibara, Minoru
    PHARMACOLOGICAL RESEARCH, 2009, 60 (04) : 237 - 246
12345